There are 2137 resources available
8MO - Effective tumour growth control by combined vaccine-immune-checkpoint inhibition in MLH1-/- mice
Presenter: Claudia Maletzki
Session: Mini Oral - Basic Science
Resources:
Abstract
Slides
Webcast
1978MO - Tumour-infiltrating macrophages, PD-L1 and tumour/stroma ratio as independent prognostic factors in a well-defined European cohort of patients with oral squamous cell carcinoma
Presenter: Pieter Demetter
Session: Mini Oral - Basic Science
Resources:
Abstract
Slides
Webcast
1979MO - Inhibition of fatty acid synthase (FASN) activity induces cytotoxicity on gefitinib- and osimertinib-resistant EGFR-mutated non-small cell lung cancer cells
Presenter: Emma Polonio
Session: Mini Oral - Basic Science
Resources:
Abstract
Slides
Webcast
6MO - Radiochemotherapy-induced changes in brain extracellular matrix are associated with tumour development in mouse recurrent glioblastoma model
Presenter: Alexandra Tsidulko
Session: Mini Oral - Basic Science
Resources:
Abstract
Slides
Webcast
1980MO - SENP1 knockdown suppresses tumour progression in lung adenocarcinoma by regulating AAT genes expression
Presenter: HONG CHENG
Session: Mini Oral - Basic Science
Resources:
Abstract
Slides
Webcast
9MO - C-Myc regulates the cancer stem-cell phenotype differentially induced by the individual silencing of AKT isoforms in pancreatic adenocarcinoma
Presenter: Hugo Arasanz
Session: Mini Oral - Basic Science
Resources:
Abstract
Slides
Webcast
LBA13 - Tumour infiltrating lymphocytes (TILs), PD-L1 expression and their dynamics in the NeoTRIPaPDL1 trial
Presenter: Giampaolo Bianchini
Session: Mini Oral - Breast cancer, early stage
Resources:
Abstract
Slides
Webcast
162MO - Neoadjuvant chemotherapy and immunotherapy in Luminal B BC: Results of the phase II GIADA trial
Presenter: Maria Vittoria Dieci
Session: Mini Oral - Breast cancer, early stage
Resources:
Abstract
Slides
Webcast
163MO - Randomized phase II study of eribulin-based neoadjuvant chemotherapy for triple-negative primary breast cancer patients stratified by homologous recombination deficiency status (JBCRG-22)
Presenter: Hiroko Bando
Session: Mini Oral - Breast cancer, early stage
Resources:
Abstract
Slides
Webcast
164MO - Impaired Ki67 response towards neoadjuvant endocrine therapy in luminal breast cancer is associated with mutations conferring endocrine resistance: WSG-ADAPT HR+/HER2- translational results
Presenter: Isabel Grote
Session: Mini Oral - Breast cancer, early stage
Resources:
Abstract
Slides
Webcast